Preeti Gupta1,2, Ching-Yu Cheng1,2,3,4, Chui Ming Gemmy Cheung1,2,4, Hla Myint Htoon1,4, Yingfeng Zheng1, Ecosse L Lamoureux1,2,4, Tin Aung1,2,4, Tien-Yin Wong1,2,4, Carol Y Cheung1,2,4. 1. Singapore Eye Research Institute and Singapore National Eye Centre, Singapore, Singapore. 2. Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, Singapore. 3. Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore. 4. Office of Clinical Sciences, Duke-NUS Graduate Medical School, Singapore, Singapore.
Abstract
PURPOSE: To assess the visibility of the choroidal-scleral interface (CSI) from spectral domain optical coherence tomography (SD-OCT) and evaluate the ocular and systemic factors influencing the visibility of CSI in healthy eyes from population-based Malay sample. METHODS: Participants were consecutively recruited from the population-based Singapore Malay Eye Study-2 (SiMES-2). SD-OCT images were obtained by Spectralis OCT with enhanced depth imaging (EDI) mode. Visibility of CSI was assessed by a grading system ranging from 0 to 2 scores. The reliability of choroidal thickness measurement in different grades of CSI visibility was assessed using intraclass correlation coefficient. Ordinal regression analyses were performed to evaluate a range of ocular and systemic factors influencing the visibility of CSI. RESULTS: A total of 176 healthy eyes were analysed, and 59.1% of our subjects had well-defined CSI (score 2), 8.5% had poorly defined CSI (score 0), and 32.4% had CSI between well and poorly defined (score 1). The reliability of subfoveal choroidal thickness measurement decreased with each grade of CSI visibility score. Decreased axial length (AL) (estimate of ordinal regression [OR] = 0.465, p = 0.003), thicker retinal thickness (estimate of OR = -0.030, p = 0.004), younger age (estimate of OR = 0.045, p = 0.030) and diabetes (estimate of OR = -0.746, p = 0.004) were associated with lower CSI visibility score. CONCLUSIONS: Only 60% of normal healthy eyes had well-defined CSI from SD-OCT images. Our data suggest that choroidal thickness measurements can be substantially affected by the visibility of CSI. The visibility of CSI varies with AL, retinal thickness, age and diabetes.
PURPOSE: To assess the visibility of the choroidal-scleral interface (CSI) from spectral domain optical coherence tomography (SD-OCT) and evaluate the ocular and systemic factors influencing the visibility of CSI in healthy eyes from population-based Malay sample. METHODS:Participants were consecutively recruited from the population-based Singapore Malay Eye Study-2 (SiMES-2). SD-OCT images were obtained by Spectralis OCT with enhanced depth imaging (EDI) mode. Visibility of CSI was assessed by a grading system ranging from 0 to 2 scores. The reliability of choroidal thickness measurement in different grades of CSI visibility was assessed using intraclass correlation coefficient. Ordinal regression analyses were performed to evaluate a range of ocular and systemic factors influencing the visibility of CSI. RESULTS: A total of 176 healthy eyes were analysed, and 59.1% of our subjects had well-defined CSI (score 2), 8.5% had poorly defined CSI (score 0), and 32.4% had CSI between well and poorly defined (score 1). The reliability of subfoveal choroidal thickness measurement decreased with each grade of CSI visibility score. Decreased axial length (AL) (estimate of ordinal regression [OR] = 0.465, p = 0.003), thicker retinal thickness (estimate of OR = -0.030, p = 0.004), younger age (estimate of OR = 0.045, p = 0.030) and diabetes (estimate of OR = -0.746, p = 0.004) were associated with lower CSI visibility score. CONCLUSIONS: Only 60% of normal healthy eyes had well-defined CSI from SD-OCT images. Our data suggest that choroidal thickness measurements can be substantially affected by the visibility of CSI. The visibility of CSI varies with AL, retinal thickness, age and diabetes.
Authors: Vivian S Vuong; Elad Moisseiev; David Cunefare; Sina Farsiu; Ala Moshiri; Glenn Yiu Journal: Am J Ophthalmol Date: 2016-06-23 Impact factor: 5.258
Authors: Tin A Tun; Xiaofei Wang; Mani Baskaran; Monisha E Nongpiur; Yih-Chung Tham; Shamira A Perera; Nicholas G Strouthidis; Tin Aung; Ching-Yu Cheng; Michaël J A Girard Journal: Invest Ophthalmol Vis Sci Date: 2019-08-01 Impact factor: 4.799
Authors: Otilia Obadă; Anca Delia Pantalon; Gabriela Rusu-Zota; Anca Hăisan; Ioana Smaranda Lupuşoru; Daniel George Boicu; Dorin Chiseliţă Journal: Rom J Ophthalmol Date: 2021 Jul-Sep
Authors: Erica W T Kung; Victor T T Chan; Ziqi Tang; Dawei Yang; Zihan Sun; Yu Meng Wang; C H Chan; Michael C H Kwan; Jian Shi; Carol Y Cheung Journal: Ophthalmol Sci Date: 2022-02-25